propranolol has been researched along with von Willebrand Diseases in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
von Willebrand Diseases: Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Platelet function was investigated in four normal volunteers, one patient with a mild form of von Willebrand disease, and one with a thrombocytopathy, all taking propranolol." | 3.66 | Some observations on the in vivo effect of propranolol on platelet aggregation and release. ( Leon, R; Pechet, L; Tiarks, CY, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krikis, N | 1 |
| Tziomalos, K | 1 |
| Perifanis, V | 1 |
| Vakalopoulou, S | 1 |
| Karagiannis, A | 1 |
| Garipidou, V | 1 |
| Harsoulis, F | 1 |
| Leon, R | 1 |
| Tiarks, CY | 1 |
| Pechet, L | 1 |
| Hoak, JC | 1 |
| Wilson, WR | 1 |
| Warner, ED | 1 |
| Theilen, EO | 1 |
| Fry, GL | 1 |
| Benoit, FL | 1 |
3 other studies available for propranolol and von Willebrand Diseases
| Article | Year |
|---|---|
Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propranolol.
Topics: Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Octreotide; Propr | 2005 |
Some observations on the in vivo effect of propranolol on platelet aggregation and release.
Topics: Adult; Blood Platelet Disorders; Blood Platelets; Female; Humans; Male; Middle Aged; Platelet Aggreg | 1978 |
Effects of triiodothyronine-induced hypermetabolism on factor 8 and fibrinogen in man.
Topics: Basal Metabolism; Epinephrine; Factor VIII; Fibrinogen; Hemophilia A; Humans; Hyperthyroidism; Male; | 1969 |